Merz is a global healthcare company based in Germany, known for its innovative products in the fields of aesthetics, neurology, and dermatology. Founded in 1908, the company focuses on developing treatments that enhance quality of life, particularly in areas like botulinum toxin and dermal fillers. In addition to its aesthetic offerings, Merz is involved in research and development for neurological disorders, providing solutions for conditions such as Alzheimer's disease and multiple sclerosis. The company emphasizes scientific advancement and patient care, aiming to improve health outcomes worldwide.